In the last trading session, 2.11 million Ernexa Therapeutics Inc (NASDAQ:ERNA) shares changed hands as the company’s beta touched 5.57. With the company’s per share price at $0.16 changed hands at -$0.03 or -17.99% during last session, the market valuation stood at $9.67M. ERNA’s last price was a discount, traded about -1537.5% off its 52-week high of $2.62. The share price had its 52-week low at $0.15, which suggests the last value was 6.25% up since then.

Ernexa Therapeutics Inc (NASDAQ:ERNA) trade information

Instantly ERNA was in red as seen at the end of in last trading. With action -13.79%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -47.28%, with the 5-day performance at -13.79% in the red. However, in the 30-day time frame, Ernexa Therapeutics Inc (NASDAQ:ERNA) is -22.34% down.

Ernexa Therapeutics Inc (NASDAQ:ERNA)’s Major holders

NAVITER WEALTH, LLC holds the second largest percentage of outstanding shares, with 1.4565% or 78796.0 shares worth $0.14 million as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 198.81 shares estimated at $30814.0 under it, the former controlled 0.32% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.08% of the shares, roughly 47.9 shares worth around $7423.0.